Agile Regulatory

Agile Regulatory

ผู้เยี่ยมชม

  https://docs.crypterium.com/discuss/694a564d1580f09fb6f67e41 (64 อ่าน)

23 ธ.ค. 2568 15:55

<div class="pointer-events-none h-px w-px absolute bottom-0" data-edge="true"> </div>


<div class="flex flex-col text-sm pb-25">
<article class="text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [&:has([data-writing-block])>*]:pointer-events-auto [content-visibility:auto] supports-[content-visibility:auto]:[contain-intrinsic-size:auto_100lvh] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" tabindex="-1" data-turn-id="request-WEB:a160a515-760f-4f8f-b6e6-3d19c16c28df-0" data-testid="conversation-turn-2" data-scroll-anchor="true" data-turn="assistant">
<div class="text-base my-auto mx-auto pb-10 [--thread-content-margin:--spacing(4)] @w-sm/main:[--thread-content-margin:--spacing(6)] @w-lg/main:[--thread-content-margin:--spacing(16)] px-(--thread-content-margin)">
<div class="[--thread-content-max-width:40rem] @w-lg/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn" tabindex="-1">
<div class="flex max-w-full flex-col grow">
<div class="min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&]:mt-1" dir="auto" data-message-author-role="assistant" data-message-id="022fa284-cf65-4b09-a1f8-de396b6b3c92" data-message-model-slug="gpt-5-2">
<div class="flex w-full flex-col gap-1 empty:hidden first:pt-[1px]">
<div class="markdown prose dark:prose-invert w-full break-words dark markdown-new-styling">
<p data-start="95" data-end="843" data-is-last-node="" data-is-only-node="">The MD 42 License is a mandatory regulatory approval issued under the Drugs and Cosmetics Act, 1940, for pharmaceutical manufacturers in India. It authorizes companies to manufacture drugs for sale or distribution while ensuring strict compliance with GMP standards, quality control, and safety norms. Obtaining an MD 42 license involves documentation, facility inspection, technical staff qualification verification, and adherence to CDSCO and State Drug Authority guidelines. This forum discussion explores eligibility criteria, application procedure, timelines, common challenges, and compliance requirements related to the MD 42 license, helping pharma businesses streamline approvals and avoid regulatory delays.

</div>
</div>
</div>
</div>
<div class="z-0 flex min-h-[46px] justify-start"> </div>
<div class="mt-3 w-full empty:hidden"> </div>
</div>
</div>
</article>
</div>

Agile Regulatory

Agile Regulatory

ผู้เยี่ยมชม

เว็บไซต์นี้มีการใช้งานคุกกี้ เพื่อเพิ่มประสิทธิภาพและประสบการณ์ที่ดีในการใช้งานเว็บไซต์ของท่าน ท่านสามารถอ่านรายละเอียดเพิ่มเติมได้ที่ นโยบายความเป็นส่วนตัว  และ  นโยบายคุกกี้